1 asset in Tongue Squamous Cell Carcinoma
Therapeutic assets addressing Tongue Squamous Cell Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Evolve104 Tongue Squamous Cell Carcinoma | EvolveImmune United, Inc | P1 | NR () |